Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 172,677 | 183,118 | 188,530 | 201,039 | 200,023 |
| Receivables | 858 | 871 | 993 | 945 | 935 |
| TOTAL | $174,567 | $185,034 | $190,639 | $203,056 | $201,718 |
| Non-Current Assets | |||||
| PPE Net | 24,526 | 24,817 | 24,916 | 24,802 | 24,897 |
| TOTAL | $24,526 | $24,817 | $24,916 | $24,802 | $24,897 |
| Total Assets | $199,093 | $209,851 | $215,555 | $227,858 | $226,615 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,250 | 10,000 | 10,000 | 10,000 | N/A |
| Accounts payable and accrued liabilities | 2,223 | 1,506 | 1,704 | 2,607 | 2,516 |
| Accrued Expenses | 2,632 | 4,486 | 5,348 | 4,194 | 3,501 |
| TOTAL | $15,105 | $15,992 | $17,135 | $16,884 | $6,100 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,720 | 1,744 | 1,719 | 1,694 | 1,669 |
| TOTAL | $1,720 | $1,744 | $1,719 | $1,694 | $1,669 |
| Total Liabilities | $16,825 | $17,736 | $18,854 | $18,578 | $7,769 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,488 | 30,483 | 30,463 | 30,458 | 30,451 |
| Common Shares | 273,105 | 272,444 | 272,015 | 271,588 | 271,152 |
| Retained earnings | -90,837 | -80,329 | -75,314 | -62,308 | -52,306 |
| TOTAL | $182,268 | $192,115 | $196,701 | $209,280 | $218,846 |
| Total Liabilities And Equity | $199,093 | $209,851 | $215,555 | $227,858 | $226,615 |